Cabazitaxel-platinum nanoparticles and methods of using same
US9480657B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 17, 2014 |
| Grant date | Nov 1, 2016 |
| Priority date | — |
| Expiry date | Mar 17, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum compound having a heterocycle ligand. Cabazitaxel-platinum nanoparticles are disclosed herein, as well as methods of making and using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.